Morgan, G. J., Davies, F. E., Gregory, W. M., Bell, S. E., Szubert, A. J., Navarro Coy, N., . . . Child, J. A. (2012). Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results. Ferrata Storti Foundation.
Citação norma ChicagoMorgan, Gareth J., et al. Cyclophosphamide, Thalidomide, and Dexamethasone As Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Destined for Autologous Stem-cell Transplantation: MRC Myeloma IX Randomized Trial Results. Ferrata Storti Foundation, 2012.
Citação norma MLAMorgan, Gareth J., et al. Cyclophosphamide, Thalidomide, and Dexamethasone As Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Destined for Autologous Stem-cell Transplantation: MRC Myeloma IX Randomized Trial Results. Ferrata Storti Foundation, 2012.